Adverse reactions to antiretrovirals presented by HIV patients: a scientific
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , , , , , , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/13308 |
Resumo: | HIV patients start their treatments in the Unified Health System (SUS) through the Family Health Strategy Assistance (ESF) and this, in turn, coordinates all care provided and the referral of the patient to a reference unit for counseling, monitoring and control of infection in an integral and resolutive way. However, we hope that this work will contribute to understanding the types of adverse reactions that have occurred by users of HIV medications. All publications that have data on pharmacological treatments for HIV were used, from a certain date (2019-2020). Data were collected using the scientific databases: Latin American and Caribbean Literature in Health Sciences (LILACS), National Library of medicine (PUBMED), PERIODICOS, SCIENCE DIRECT, Virtual Health Library ( VHL), Scientific Electronic Library Online (SCIELO) and Cochrane Library; and the technological bases: World Intellectual Property Organization (WIPO) and National Institute of Industrial Property (INPI). We use AS DEScriptors: ADVERSE REACTIONS TO ANTIRETROVIRAL DRUGS, ADVERSE REACTIONS TO ANTIRETROVIRAL DRUGS IN PREGNANT WOMEN and ANTIRETRORETROVIRAL. The publishing language was in Portuguese, English and Spanish, attending a historical series of at least five years. A number of articles were observed on the scientific database. This treatment of the virus does not cure because of the persistent accumulation of latentemente infected cells. Even with mild symptoms, they can lead to a decrease in the quality of life of the carrier, thus necessary more research on the subject. We must remember that their quality of life directly impacts our society and therefore matters to everyone. |
id |
UNIFEI_689ec3e3c1e99a44ec4aaccdf8c14a85 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/13308 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Adverse reactions to antiretrovirals presented by HIV patients: a scientific Reacciones adversas a antirretrovirales presentadas por pacientes con VIH: una revisión científica Reações adversas aos antirretrovirais apresentadas pelos portadores de HIV AntiretroviralsSide effectHIVNeglected diseasePublic health.AntirretroviralesEfecto colateralHIVEnfermedad desatendidaSalud pública.AntirretroviraisEfeito colateralHIVDoença negligenciadaSaúde pública.HIV patients start their treatments in the Unified Health System (SUS) through the Family Health Strategy Assistance (ESF) and this, in turn, coordinates all care provided and the referral of the patient to a reference unit for counseling, monitoring and control of infection in an integral and resolutive way. However, we hope that this work will contribute to understanding the types of adverse reactions that have occurred by users of HIV medications. All publications that have data on pharmacological treatments for HIV were used, from a certain date (2019-2020). Data were collected using the scientific databases: Latin American and Caribbean Literature in Health Sciences (LILACS), National Library of medicine (PUBMED), PERIODICOS, SCIENCE DIRECT, Virtual Health Library ( VHL), Scientific Electronic Library Online (SCIELO) and Cochrane Library; and the technological bases: World Intellectual Property Organization (WIPO) and National Institute of Industrial Property (INPI). We use AS DEScriptors: ADVERSE REACTIONS TO ANTIRETROVIRAL DRUGS, ADVERSE REACTIONS TO ANTIRETROVIRAL DRUGS IN PREGNANT WOMEN and ANTIRETRORETROVIRAL. The publishing language was in Portuguese, English and Spanish, attending a historical series of at least five years. A number of articles were observed on the scientific database. This treatment of the virus does not cure because of the persistent accumulation of latentemente infected cells. Even with mild symptoms, they can lead to a decrease in the quality of life of the carrier, thus necessary more research on the subject. We must remember that their quality of life directly impacts our society and therefore matters to everyone.Los pacientes con VIH inician sus tratamientos en el Sistema Unificado de Salud (SUS) a través de la Ayuda a la Estrategia de Salud Familiar (FSE) y esto, a su vez, coordina toda la atención prestada y la derivación del paciente a una unidad de referencia para el asesoramiento, seguimiento y control de la infección de forma integral y resolutiva. Sin embargo, esperamos que este trabajo contribuya a comprender los tipos de reacciones adversas que han producido los usuarios de medicamentos contra el VIH. Todas las publicaciones que tienen datos sobre tratamientos farmacológicos para el VIH se utilizaron, a partir de una fecha determinada (2019-2020). Los datos fueron recopilados utilizando las bases de datos científicas: Literatura Latinoamericana y del Caribe en Ciencias de la Salud (LILACS), Biblioteca Nacional de Medicina (PUBMED), PERIODICOS, SCIENCE DIRECT, Biblioteca Virtual de Salud (VHL), Biblioteca Electrónica Científica en Línea (SCIELO) y Biblioteca Cochrane; y las bases tecnológicas: Organización Mundial de la Propiedad Intelectual (OMPI) y Instituto Nacional de la Propiedad Industrial (INPI). Utilizamos como descriptores: REACCIONES ADVERSAS A MEDICAMENTOS ANTIRRETROVIRALES, REACCIONES ADVERSAS A MEDICAMENTOS ANTIRRETROVIRALES EN MUJERES EMBARAZADAS Y ANTIRRETRORETROVIRALES. El idioma editorial estaba en portugués, inglés y español, asistiendo a una serie histórica de al menos cinco años. Se observaron varios artículos en la base de datos científica. Este tratamiento del virus no se cura debido a la acumulación persistente de células infectadas por latentemente. Incluso con síntomas leves, pueden conducir a una disminución en la calidad de vida del portador, por lo tanto, es necesario más investigación sobre el tema. Debemos recordar que su calidad de vida afecta directamente a nuestra sociedad y, por lo tanto, importa a todos.Os portadores de HIV iniciam seus tratamentos no do Sistema Único de Saúde (SUS) através da Assistência da Estratégia da Saúde da Família (ESF) e esta, por sua vez, coordena todos os cuidados prestados e o encaminhamento do paciente a uma unidade de referência para aconselhamento, acompanhamento e controle da infecção de forma integral e resolutiva. Contudo esperamos que este trabalho contribua para compreendermos os tipos de reações adversas ocorridas pelos usuários dos medicamentos para tratamento do HIV. Foram utilizadas todas as publicações que possuírem dados de tratamentos farmacológicos para HIV, dentre a determinada data (2019-2020). Os dados foram coletados utilizando as bases cientificas: Literatura Latino-Americana e do Caribe em Ciências da Saúde (LILACS), National Library of medicine (PUBMED), PERIODICOS, SCIENCE DIRECT, Biblioteca Virtual em saúde – (BVS), Scientific Eletronic Library Online (SCIELO) e Cochrane Library; e as bases tecnológicas: World Intellectual Property Organization (WIPO) e Instituto Nacional de Propriedade Industrial (INPI). Utilizamos como descritores: REAÇÕES ADVERSAS AOS ANTIRRETROVIRAIS, REAÇÕES ADVERSAS AOS ANTIRRETROVIRAIS EM GESTANTES e ANTIRRETROVIRAIS. O idioma de publicação estava em português, inglês e espanhol, atendendo a uma série histórica de pelo menos cinco anos. Foi observado 208.425 artigos nas bases cientificas. Esse tratamento do vírus não cura por conta do acumulo persistente de células infectadas latentemente. Mesmo com sintomas leves, podem levar a uma diminuição da qualidade de vida do portador, assim necessário mais pesquisas sobre o tema. Devemos lembrar que a qualidade de vida deles, impacta diretamente na nossa sociedade e, portanto, importa a todos.Research, Society and Development2021-03-23info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1330810.33448/rsd-v10i3.13308Research, Society and Development; Vol. 10 No. 3; e50210313308Research, Society and Development; Vol. 10 Núm. 3; e50210313308Research, Society and Development; v. 10 n. 3; e502103133082525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/13308/12226Copyright (c) 2021 Stefanya Cristina Carvalho Moura; Sérgio Ricardo da Cruz Ferreira Junior; Maria Ramel de Sousa Silva Matias; Kelly Maria Rêgo da Silva; Higo José Neri da Silva; Pauliana Texeira da Silva; Ana Maria Castro Ferreira; Wallyson André dos Santos Bezerra; Denilson de Araújo e Silva; Mariel Rodrigues de Campos; Antonia Luzia Lima do Nascimento; Bruna Layra Silva; Deylane Menezes Teles e Oliveira; Alice Maria de Castro Ribeiro; Amanda Miranda da Silva; Emille Andrade Sousa; Iara Katrynne Fonsêca Oliveira; Michelle Maria Ferreira Lopes; Nathália Batista de Andrade; Denis Romulo Leite Furtadohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMoura, Stefanya Cristina Carvalho Ferreira Junior, Sérgio Ricardo da Cruz Matias, Maria Ramel de Sousa Silva Silva, Kelly Maria Rêgo da Silva, Higo José Neri da Silva, Pauliana Texeira da Ferreira, Ana Maria Castro Bezerra, Wallyson André dos Santos Silva, Denilson de Araújo e Campos, Mariel Rodrigues de Nascimento, Antonia Luzia Lima do Silva, Bruna Layra Oliveira, Deylane Menezes Teles e Ribeiro, Alice Maria de Castro Silva, Amanda Miranda da Sousa, Emille Andrade Oliveira, Iara Katrynne Fonsêca Lopes, Michelle Maria Ferreira Andrade, Nathália Batista de Furtado, Denis Romulo Leite 2021-03-28T12:03:35Zoai:ojs.pkp.sfu.ca:article/13308Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:34:40.898962Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Adverse reactions to antiretrovirals presented by HIV patients: a scientific Reacciones adversas a antirretrovirales presentadas por pacientes con VIH: una revisión científica Reações adversas aos antirretrovirais apresentadas pelos portadores de HIV |
title |
Adverse reactions to antiretrovirals presented by HIV patients: a scientific |
spellingShingle |
Adverse reactions to antiretrovirals presented by HIV patients: a scientific Moura, Stefanya Cristina Carvalho Antiretrovirals Side effect HIV Neglected disease Public health. Antirretrovirales Efecto colateral HIV Enfermedad desatendida Salud pública. Antirretrovirais Efeito colateral HIV Doença negligenciada Saúde pública. |
title_short |
Adverse reactions to antiretrovirals presented by HIV patients: a scientific |
title_full |
Adverse reactions to antiretrovirals presented by HIV patients: a scientific |
title_fullStr |
Adverse reactions to antiretrovirals presented by HIV patients: a scientific |
title_full_unstemmed |
Adverse reactions to antiretrovirals presented by HIV patients: a scientific |
title_sort |
Adverse reactions to antiretrovirals presented by HIV patients: a scientific |
author |
Moura, Stefanya Cristina Carvalho |
author_facet |
Moura, Stefanya Cristina Carvalho Ferreira Junior, Sérgio Ricardo da Cruz Matias, Maria Ramel de Sousa Silva Silva, Kelly Maria Rêgo da Silva, Higo José Neri da Silva, Pauliana Texeira da Ferreira, Ana Maria Castro Bezerra, Wallyson André dos Santos Silva, Denilson de Araújo e Campos, Mariel Rodrigues de Nascimento, Antonia Luzia Lima do Silva, Bruna Layra Oliveira, Deylane Menezes Teles e Ribeiro, Alice Maria de Castro Silva, Amanda Miranda da Sousa, Emille Andrade Oliveira, Iara Katrynne Fonsêca Lopes, Michelle Maria Ferreira Andrade, Nathália Batista de Furtado, Denis Romulo Leite |
author_role |
author |
author2 |
Ferreira Junior, Sérgio Ricardo da Cruz Matias, Maria Ramel de Sousa Silva Silva, Kelly Maria Rêgo da Silva, Higo José Neri da Silva, Pauliana Texeira da Ferreira, Ana Maria Castro Bezerra, Wallyson André dos Santos Silva, Denilson de Araújo e Campos, Mariel Rodrigues de Nascimento, Antonia Luzia Lima do Silva, Bruna Layra Oliveira, Deylane Menezes Teles e Ribeiro, Alice Maria de Castro Silva, Amanda Miranda da Sousa, Emille Andrade Oliveira, Iara Katrynne Fonsêca Lopes, Michelle Maria Ferreira Andrade, Nathália Batista de Furtado, Denis Romulo Leite |
author2_role |
author author author author author author author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Moura, Stefanya Cristina Carvalho Ferreira Junior, Sérgio Ricardo da Cruz Matias, Maria Ramel de Sousa Silva Silva, Kelly Maria Rêgo da Silva, Higo José Neri da Silva, Pauliana Texeira da Ferreira, Ana Maria Castro Bezerra, Wallyson André dos Santos Silva, Denilson de Araújo e Campos, Mariel Rodrigues de Nascimento, Antonia Luzia Lima do Silva, Bruna Layra Oliveira, Deylane Menezes Teles e Ribeiro, Alice Maria de Castro Silva, Amanda Miranda da Sousa, Emille Andrade Oliveira, Iara Katrynne Fonsêca Lopes, Michelle Maria Ferreira Andrade, Nathália Batista de Furtado, Denis Romulo Leite |
dc.subject.por.fl_str_mv |
Antiretrovirals Side effect HIV Neglected disease Public health. Antirretrovirales Efecto colateral HIV Enfermedad desatendida Salud pública. Antirretrovirais Efeito colateral HIV Doença negligenciada Saúde pública. |
topic |
Antiretrovirals Side effect HIV Neglected disease Public health. Antirretrovirales Efecto colateral HIV Enfermedad desatendida Salud pública. Antirretrovirais Efeito colateral HIV Doença negligenciada Saúde pública. |
description |
HIV patients start their treatments in the Unified Health System (SUS) through the Family Health Strategy Assistance (ESF) and this, in turn, coordinates all care provided and the referral of the patient to a reference unit for counseling, monitoring and control of infection in an integral and resolutive way. However, we hope that this work will contribute to understanding the types of adverse reactions that have occurred by users of HIV medications. All publications that have data on pharmacological treatments for HIV were used, from a certain date (2019-2020). Data were collected using the scientific databases: Latin American and Caribbean Literature in Health Sciences (LILACS), National Library of medicine (PUBMED), PERIODICOS, SCIENCE DIRECT, Virtual Health Library ( VHL), Scientific Electronic Library Online (SCIELO) and Cochrane Library; and the technological bases: World Intellectual Property Organization (WIPO) and National Institute of Industrial Property (INPI). We use AS DEScriptors: ADVERSE REACTIONS TO ANTIRETROVIRAL DRUGS, ADVERSE REACTIONS TO ANTIRETROVIRAL DRUGS IN PREGNANT WOMEN and ANTIRETRORETROVIRAL. The publishing language was in Portuguese, English and Spanish, attending a historical series of at least five years. A number of articles were observed on the scientific database. This treatment of the virus does not cure because of the persistent accumulation of latentemente infected cells. Even with mild symptoms, they can lead to a decrease in the quality of life of the carrier, thus necessary more research on the subject. We must remember that their quality of life directly impacts our society and therefore matters to everyone. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-03-23 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/13308 10.33448/rsd-v10i3.13308 |
url |
https://rsdjournal.org/index.php/rsd/article/view/13308 |
identifier_str_mv |
10.33448/rsd-v10i3.13308 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/13308/12226 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 3; e50210313308 Research, Society and Development; Vol. 10 Núm. 3; e50210313308 Research, Society and Development; v. 10 n. 3; e50210313308 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052672297140224 |